- NVMI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
-
Insider
- Institutional
- Shorts
-
6-K Filing
Nova (NVMI) 6-KCurrent report (foreign)
Filed: 7 Nov 19, 8:00am
NOVA MEASURING INSTRUMENTS LTD. | |||
(Registrant) | |||
Date: November 7, 2019 | By: | /s/ Dror David | |
Dror David | |||
Chief Financial Officer |
Company Contact: Dror David, Chief Financial Officer Nova Measuring Instruments Ltd. Tel: +972-73-229-5760 E-mail: info@novami.com www.novami.com | Investor Relations Contact: Miri Segal MS-IR LLC Tel: +917-607-8654 E-mail: msegal@ms-ir.com |
• | Quarterly revenue of $52.5 million, meeting guidance of $46 million to $54 million. |
• | GAAP net income of $8.6 million, or $0.30 per diluted share, exceeding guidance of $0.11 to $0.24 per share |
• | Non-GAAP net income of $11.5 million, or $0.40 per diluted share, exceeding guidance of $0.20 to $0.34 per share |
• | Accelerated deliveries to leading edge Foundry to support expansion of its most advanced technology node |
• | Balanced revenue contribution across segments, geographies and customers |
GAAP Results ($K) | |||
Q3 2019 | Q2 2019 | Q3 2018 | |
Revenues | $52,507 | $51,120 | $63,571 |
Net Income | $8,562 | $6,468 | $13,310 |
Earnings per Diluted Share | $0.30 | $0.23 | $0.46 |
NON-GAAP Results ($K) | |||
Q3 2019 | Q2 2019 | Q3 2018 | |
Net Income | $11,507 | $9,007 | $15,080 |
Earnings per Diluted Share | $0.40 | $0.32 | $0.52 |
• | $56 million to $62 million in revenue |
• | $0.32 to $0.42 in diluted GAAP EPS |
• | $0.40 to $0.50 in diluted non-GAAP EPS |
As of | ||||||||
September 30, 2019 | December 31, 2018 | |||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents | 26,220 | 22,877 | ||||||
Short-term interest-bearing bank deposits | 152,916 | 152,951 | ||||||
Trade accounts receivable | 47,054 | 53,531 | ||||||
Inventories | 50,143 | 41,786 | ||||||
Other current assets | 15,561 | 10,961 | ||||||
Total current assets | 291,894 | 282,106 | ||||||
Long-term assets | ||||||||
Long-term interest-bearing bank deposits | 2,000 | 2,000 | ||||||
Deferred tax assets | 4,627 | 3,873 | ||||||
Severance pay funds | 1,185 | 1,394 | ||||||
Property and equipment, net | 25,914 | 13,756 | ||||||
Identifiable intangible assets, net | 8,227 | 10,187 | ||||||
Operating lease right-of-use assets | 25,415 | - | ||||||
Goodwill | 20,114 | 20,114 | ||||||
Total long-term assets | 87,482 | 51,324 | ||||||
Total assets | 379,376 | 333,430 | ||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current liabilities | ||||||||
Trade accounts payable | 18,589 | 19,015 | ||||||
Deferred revenues | 3,715 | 3,984 | ||||||
Operating lease current liabilities | 3,620 | - | ||||||
Other current liabilities | 20,340 | 25,079 | ||||||
Total current liabilities | 46,264 | 48,078 | ||||||
Long-term liabilities | ||||||||
Liability for employee severance pay | 2,097 | 2,254 | ||||||
Operating lease long-term liabilities | 25,199 | - | ||||||
Other long-term liabilities | 5,180 | 2,358 | ||||||
Total long-term liabilities | 32,476 | 4,612 | ||||||
Shareholders' equity | 300,636 | 280,740 | ||||||
Total liabilities and shareholders’ equity | 379,376 | 333,430 |
Three months ended | Nine months ended | |||||||||||||||
September 30, 2019 | September 30, 2018 | September 30, 2019 | September 30, 2018 | |||||||||||||
Revenues: | ||||||||||||||||
Products | 38,723 | 48,953 | 120,185 | 144,922 | ||||||||||||
Services | 13,784 | 14,618 | 40,099 | 43,140 | ||||||||||||
Total revenues | 52,507 | 63,571 | 160,284 | 188,062 | ||||||||||||
Cost of revenues: | ||||||||||||||||
Products | 16,342 | 17,615 | 48,446 | 53,586 | ||||||||||||
Services | 8,672 | 8,489 | 24,651 | 24,952 | ||||||||||||
Total cost of revenues | 25,014 | 26,104 | 73,097 | 78,538 | ||||||||||||
Gross profit | 27,493 | 37,467 | 87,187 | 109,524 | ||||||||||||
Operating expenses: | ||||||||||||||||
Research and development expenses, net | 10,548 | 11,886 | 34,786 | 34,961 | ||||||||||||
Sales and marketing expenses | 7,156 | 7,016 | 20,943 | 20,689 | ||||||||||||
General and administrative expenses | 2,658 | 2,162 | 7,564 | 6,526 | ||||||||||||
Amortization of acquired intangible assets | 657 | 653 | 1,969 | 1,960 | ||||||||||||
Total operating expenses | 21,019 | 21,717 | 65,262 | 64,136 | ||||||||||||
Operating income | 6,474 | 15,750 | 21,925 | 45,388 | ||||||||||||
Financing income, net | 887 | 872 | 2,252 | 1,806 | ||||||||||||
Income before tax on income | 7,361 | 16,622 | 24,177 | 47,194 | ||||||||||||
Income tax expenses (income) | (1,201 | ) | 3,312 | 1,391 | 7,971 | |||||||||||
Net income for the period | 8,562 | 13,310 | 22,786 | 39,223 | ||||||||||||
Earnings per share: | ||||||||||||||||
Basic | 0.31 | 0.47 | 0.82 | 1.40 | ||||||||||||
Diluted | 0.30 | 0.46 | 0.80 | 1.36 | ||||||||||||
Shares used for calculation of earnings per share: | ||||||||||||||||
Basic | 27,826 | 28,047 | 27,935 | 27,980 | ||||||||||||
Diluted | 28,474 | 28,777 | 28,599 | 28,761 |
Three months ended | Nine months ended | |||||||||||||||
September 30, 2019 | September 30, 2018 | September 30, 2019 | September 30, 2018 | |||||||||||||
Cash flows from operating activities: | ||||||||||||||||
Net income for the period | 8,562 | 13,310 | 22,786 | 39,223 | ||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||
Depreciation and amortization | 3,842 | 2,000 | 9,312 | 5,534 | ||||||||||||
Amortization of deferred stock-based compensation | 1,364 | 1,254 | 3,662 | 3,081 | ||||||||||||
Decrease (increase) in liability for employee termination benefits, net | 25 | (18 | ) | 52 | (53 | ) | ||||||||||
Deferred tax assets, net | (410 | ) | (188 | ) | (754 | ) | (745 | ) | ||||||||
Decrease (increase) in trade accounts receivable | 1,024 | (4,998 | ) | 6,477 | (7,079 | ) | ||||||||||
Increase in inventories | (1,332 | ) | (768 | ) | (9,187 | ) | (8,004 | ) | ||||||||
Decrease (increase) in other current assets | (7,180 | ) | (2,505 | ) | (4,600 | ) | 1,069 | |||||||||
Increase (decrease) in trade accounts payable | 1,700 | (925 | ) | (426 | ) | 1,866 | ||||||||||
Increase (decrease) in other current liabilities and other long-term liabilities | 3,247 | (496 | ) | (1,332 | ) | (7,594 | ) | |||||||||
Decrease in short term deferred revenues | (1,599 | ) | (3,233 | ) | (269 | ) | (4,083 | ) | ||||||||
Net cash provided by operating activities | 9,243 | 3,433 | 25,721 | 23,215 | ||||||||||||
Cash flow from investment activities: | ||||||||||||||||
Decrease (increase) in short-term and long-term interest-bearing bank deposits | (6,040 | ) | *(5,761 | ) | 35 | *(24,410 | ) | |||||||||
Additions to property and equipment | (7,928 | ) | (683 | ) | (15,621 | ) | (1,779 | ) | ||||||||
Net cash used in investment activities | (13,968 | ) | *(6,444 | ) | (15,586 | ) | *(26,189 | ) | ||||||||
Cash flows from financing activities: | ||||||||||||||||
Purchases of treasury shares | - | - | (7,159 | ) | - | |||||||||||
Shares issued under employee stock-based plans | 95 | 56 | 367 | 294 | ||||||||||||
Net cash provided by (used in) financing activities | 95 | 56 | (6,792 | ) | 294 | |||||||||||
Increase (decrease) in cash and cash equivalents and restricted cash | (4,630 | ) | *(2,955 | ) | 3,343 | *(2,680 | ) | |||||||||
Cash and cash equivalents and restricted cash – beginning of period | 32,850 | *28,722 | 24,877 | *28,447 | ||||||||||||
Cash and cash equivalents and restricted cash – end of period | 28,220 | *25,767 | 28,220 | *25,767 | ||||||||||||
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheet | ||||||||||||||||
Cash and cash equivalents | 26,220 | 23,767 | 26,220 | 23,767 | ||||||||||||
Restricted cash included in Long-term interest-bearing bank deposits | 2,000 | 2,000 | 2,000 | 2,000 | ||||||||||||
Total cash, cash equivalents, and restricted cash | 28,220 | 25,767 | 28,220 | 25,767 | ||||||||||||
*reclassified |
Three months ended | ||||||||||||
September 30, 2019 | June 30, 2019 | September 30, 2018 | ||||||||||
GAAP gross profit | 27,493 | 28,110 | 37,467 | |||||||||
Stock-based compensation expenses (1) | 277 | 222 | 283 | |||||||||
Facilities transition costs (2) | 220 | 271 | - | |||||||||
Non-GAAP gross profit | 27,990 | 28,603 | 37,750 | |||||||||
GAAP gross margin as a percentage of revenues | 52 | % | 55 | % | 59 | % | ||||||
Non-GAAP gross margin as a percentage of revenues | 53 | % | 56 | % | 59 | % | ||||||
GAAP operating income | 6,474 | 6,775 | 15,750 | |||||||||
Stock-based compensation expenses (1) | 1,364 | 1,086 | 1,254 | |||||||||
Amortization of acquired intangible assets | 657 | 656 | 653 | |||||||||
Facilities transition costs (2) | 888 | 827 | - | |||||||||
Non-GAAP operating income | 9,383 | 9,344 | 17,657 | |||||||||
GAAP operating margin as a percentage of revenues | 12 | % | 13 | % | 25 | % | ||||||
Non-GAAP operating margin as a percentage of revenues | 18 | % | 18 | % | 28 | % | ||||||
GAAP net income | 8,562 | 6,468 | 13,310 | |||||||||
Stock-based compensation expenses (1) | 1,364 | 1,086 | 1,254 | |||||||||
Amortization of acquired intangible assets | 657 | 656 | 653 | |||||||||
Facilities transition costs (2) | 888 | 827 | - | |||||||||
Revaluation of long-term liabilities | 362 | 295 | - | |||||||||
Tax effect of non-GAAP adjustments | (326 | ) | (325 | ) | (137 | ) | ||||||
Non-GAAP net income | 11,507 | 9,007 | 15,080 | |||||||||
GAAP basic earnings per share | 0.31 | 0.23 | 0.47 | |||||||||
Non-GAAP basic earnings per share | 0.41 | 0.32 | 0.54 | |||||||||
GAAP diluted earnings per share | 0.30 | 0.23 | 0.46 | |||||||||
Non-GAAP diluted earnings per share | 0.40 | 0.32 | 0.52 | |||||||||
Shares used for calculation of earnings per share: | ||||||||||||
Basic | 27,826 | 27,869 | 28,047 | |||||||||
Diluted | 28,474 | 28,564 | 28,777 |
(1) | Stock-based compensation expenses for the three months ended September 30, 2019 included in – Cost of revenues products - 161; Cost of revenues services - 116; Research and development expenses, net – 534; Sales and marketing expenses – 296; General and administrative expenses – 257. |
(2) | Facilities transition costs for the three months ended September 30, 2019 included in – Cost of revenues products - 144; Cost of revenues services - 76; Research and development expenses, net – 295; Sales and marketing expenses – 110; General and administrative expenses – 264. |